DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo


1.85 -0.02 (-1.07%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMRS $1.85 -1.07%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.87
Previous Close $1.87
Daily Range $1.79 - $1.88
52-Week Range $1.56 - $5.25
Market Cap $146.3M
P/E Ratio -0.67
Dividend (Yield) $0.00 (0.0%)
Volume 74,142
Average Daily Volume 245,529
Current FY EPS -$1.23






Amyris Inc. is building a renewable products company by applying its industrial synthetic biology technology platform to provide alternatives to select petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide. Website:

News & Commentary Rss Feed

British Invasion: Why is America Producing Fuel for This WWII Airplane?

Watch out, petroleum. This British biotech company is fueling the comeback of biobutanol-- something last produced during World War II.

Stocks Hitting 52-Week Lows

1 Big Oil Company That Sees a Future in Renewable Energy

Not many oil companies are betting on renewables, but this French oil giant is betting billions that solar and biotech will be a big part of its future.

This Technology Could Create Cheaper Marijuana Drugs

Plant-based manufacturing has many inefficiencies, but that doesn't mean marijuana drugs are doomed. New technology could create the same cannabinoids -- without the plant.

Amyris (AMRS) in Focus: Stock Falls 6.2% - Tale of the Tape

Why Amyris Is My Favorite Stock to Buy in 2015

Falling production costs will allow Amyris to double production capacity in 2015, and likely again in 2016, while also allowing the company to profitably enter multiple markets. Time to take a closer look.

Falling Oil Prices Could Kill Environmentally-Friendly Jet Fuels

Falling oil prices will boost profits in the airline industry, but could hamper plans to switch to more environmentally-friendly options.

This Gene Editing Technology Is About to Change Healthcare and GMOs Forever

A former AbbVie executive recently said, "We talk about paradigm shifts a lot in this industry, but this really is." What makes gene-editing platforms so promising and inevitable -- and what stocks are at risk of becoming obsolete?

Energy Investing: 4 Reasons We're Excited for 2015

The Motley Fool asked the analysts knee-deep in the energy sector what they're excited about for 2015.

Why Amyris (AMRS) Could Be Positioned for a Slump - Tale of the Tape

See More AMRS News...

AMRS's Top Competitors

AMRS $1.85 (-1.07%)
Current stock: AMRS
FCEL $1.13 (0.89%)
Current stock: FCEL
RTK $1.22 (-2.40%)
Current stock: RTK
SZYM $2.31 (9.48%)
Current stock: SZYM